Cerevance thik-1
WebNov 7, 2024 · Title: Identification of THIK-1 as a therapeutic target for Alzheimer's disease and characterization of a selective and novel blocker Presentation Number: 366.05 Presenter: Madhurima Dey ... WebApr 13, 2024 · Title: NETSseq platform identifies KCNK13 (THIK-1) as a target to modulate neuroinflammation in Alzheimer’s disease Overview: The NETSseq platform can identify novel druggable microglia targets, exemplified by KCNK13, as potential therapies for neurodegenerative diseases. The discovery of a KCNK13 inhibitor, C101248, is described.
Cerevance thik-1
Did you know?
WebNov 15, 2024 · The presentation entitled “ Identification of THIK-1 as a Therapeutic Target For Alzheimer’s Disease: Characterisation of a Selective and Novel Blocker,” demonstrated the power of the proprietary Nuclear Enriched Transcript Sort sequencing (NETSseq) platform in identifying a novel target. Key highlights of the presentation include: WebApr 13, 2024 · BOSTON, April 13, 2024 (GLOBE NEWSWIRE) -- Cerevance, a private, clinical-stage drug discovery and development company focused on central nervous …
WebNov 30, 2024 · Cerevance’s THIK-1 targeting inhibitor, C101248, demonstrated positive results in human and mouse cell based and electrophysiology assays relevant to neuroinflammation inneurodegenerative disease Data has been concurrently published in the peer-reviewed journal, Neuropharmacology WebDec 16, 2024 · Dec. 16, 2024 Investigators from Cerevance Inc. have reported the discovery and preclinical characterization of a novel tandem pore domain halothane …
Web1 day ago · Title: NETSseq platform identifies KCNK13 (THIK-1) as a target to modulate neuroinflammation in Alzheimer’s disease Overview: ... Cerevance: Johnna Simoes, ir@ ...
WebNov 30, 2024 · Cerevance is a private pharmaceutical company whose lead therapeutic, CVN424, a first-in-class, oral, non-dopaminergic compound acting on a novel target …
WebNov 30, 2024 · Cerevance’s THIK-1 targeting inhibitor, C101248, demonstrated positive results in human and mouse cell based and electrophysiology assays relevant to … how many wives prophet muhammad hadWebJul 21, 2024 · BOSTON, July 21, 2024 (GLOBE NEWSWIRE) -- Cerevance, a private drug discovery and development company focused on brain diseases, has expanded its Series B financing round, adding $20 million to ... photography 1886WebOverall, these data suggest that THIK-1 is a regulator of NLRP3 inflammasome activation in response to ATP and identify THIK-1 as a potential therapeutic target for inflammatory … how many wives has dr phil hadWebSynopsis Ion channels are important targets for therapeutic intervention due to their extensive roles in human physiology and the pathophysiology of disease. Many successful drugs targeting this gene family have been … how many wives does tengen haveWebMar 27, 2024 · November 15, 2024 08:00 ET Source: Cerevance – Data demonstrated C101248 is a promising inhibitor of THIK-1, an emerging target in Alzheimer’s disease –– THIK-1 was identified using... how many wives has el chapo hadWebNov 15, 2024 · – Data demonstrated C101248 is a promising inhibitor of THIK-1, an emerging target in Alzheimer’s disease –– THIK-1 was identified using Cerevance’s proprietary NETSseq platform ... how many wives want an open marriageWebCerevance’s THIK-1 targeting inhibitor, C101248, demonstrated positive results in human and mouse cell based and electrophysiology assays relevant to neuroinflammation in neurodegenerative disease Data has been concurrently published in the peer-reviewed journal, Neuropharmacology photography 1tb